BCLI - BRAINSTORM CELL THERAPEUTICS INC.
0.84
-0.330 -39.286%
Share volume: 819,677
Last Updated: 07-18-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.44%
PREVIOUS CLOSE
CHG
CHG%
$1.17
-0.33
-0.28%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-14-2024 | 08-14-2024 | 11-14-2024 | 05-15-2025 | 08-14-2025 | 11-14-2025 | |
| Cash flow financing | 2.539 M | 4.370 M | 0.000 | 3.086 M | 2.701 M | 313.000 K | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -524.000 K | 0.000 | 0.000 | 1.455 M | 0.000 | 0.000 | |
| Net income | -3.401 M | -2.541 M | -2.708 M | -2.864 M | -2.903 M | -2.106 M | |
| Depreciation | 64.000 K | 64.000 K | 59.000 K | 52.000 K | 51.000 K | 48.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | -524.000 K | 2.687 M | -3.299 M | 1.455 M | -801.000 K | -789.000 K |